The Oxford/AstraZeneca vaccine fails to prevent mild and moderate cases of the South African coronavirus strain, according to research reported in the Financial Times. One of the company's top ten ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback